Duodenal mucosal ablation and proximal intestinal mucosal ablation

Discussion of the first systematic review and meta-analysis on duodenal mucosal ablation and discussion of proximal intestinal mucosal ablation, both for the treatment of type 2 diabetes.

Links:

• Proximal intestinal mucosal ablation (PIMA) for the treatment of type 2 diabetes
• Performance and safety of duodenal mucosal ablation in the management of type 2 diabetes: a systematic review and meta-analysis 

Host: Dr. Irene Perez, Moffitt Cancer Center and University of South Florida.

Participants: Dr. Rehan Haidry (Cleveland Clinic London, London, UK) and Benjamin Norton (University College London, London, UK).

 

We hope you enjoy the #FGPodcast. Please follow @‌FrontGastro_BMJ. Listen to our regular podcasts and subscribe in Apple Podcasts and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on Apple Podcasts: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229